Literature DB >> 15682373

Vascular (humoral) cardiac allograft rejection manifesting as inducible myocardial ischemia on nuclear perfusion imaging.

Kelley R Branch1, James H Caldwell, Laurie Soine, Kevin D O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15682373     DOI： 10.1016/j.nuclcard.2004.09.019

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  7 in total

1.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

Authors:  M E Billingham; N R Cary; M E Hammond; J Kemnitz; C Marboe; H A McCallister; D C Snovar; G L Winters; A Zerbe
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

2.  Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.

Authors:  B A Pisani; G M Mullen; K Malinowska; C E Lawless; J Mendez; M A Silver; R Radvany; J A Robinson
Journal:  J Heart Lung Transplant       Date:  1999-07       Impact factor: 10.247

3.  Uptake of myocardial imaging agents by rejecting and nonrejecting cardiac transplants. A comparative clinical study of thallium-201, technetium-99m, and gallium-67.

Authors:  S Yamamoto; J Bergsland; S M Michalek; M Carroll; J M Gona; D Balu; E A Carr
Journal:  J Nucl Med       Date:  1989-09       Impact factor: 10.057

4.  Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

Authors:  Paul J Michaels; Maria L Espejo; Jon Kobashigawa; Juan C Alejos; Caron Burch; Steve Takemoto; Elaine F Reed; Michael C Fishbein
Journal:  J Heart Lung Transplant       Date:  2003-01       Impact factor: 10.247

5.  Echocardiographic assessment of cardiac allograft rejection.

Authors:  G R Ciliberto; G Cataldo; M Cipriani; M Mascarello; F Faletra; E Gronda; R De Maria; L Mauri; A Pezzano
Journal:  Eur Heart J       Date:  1989-05       Impact factor: 29.983

6.  Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.

Authors:  M A Lones; L S Czer; A Trento; D Harasty; J M Miller; M C Fishbein
Journal:  J Heart Lung Transplant       Date:  1995 Jan-Feb       Impact factor: 10.247

7.  Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.

Authors:  S C Jordan; A W Quartel; L S Czer; D Admon; G Chen; M C Fishbein; J Schwieger; R W Steiner; C Davis; D B Tyan
Journal:  Transplantation       Date:  1998-09-27       Impact factor: 4.939
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.